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The U.S. Supreme Court has decided a remarkable number of patent 
cases in the past decade, particularly as compared to the first twenty years of 
the Federal Circuit’s existence. No longer is the Federal Circuit “the de facto 
Supreme Court of patents.”1 Rather, it seems the Supreme Court is the 
Supreme Court of patents. In the article at the center of this symposium, 
Judge Dyk writes that the Supreme Court’s decisions “have had a major 
impact on patent law,” citing, among other evidence, the Court’s seventy 
 
 
 * Associate Professor, Boston University School of Law. For comments and helpful discussions, 
thanks to Jonas Anderson, Jack Beermann, Dmitry Karshtedt, Megan La Belle, Peter Lee, Rachel 
Rebouché, Greg Reilly, David Taylor, and the participants at PatCon7 at Northwestern University School 
of Law. Thanks also to Kris Hansen for valuable research assistance. 
 1. Mark D. Janis, Patent Law in the Age of the Invisible Supreme Court, 2001 U. ILL. L. REV. 387, 
387 (2001). 
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percent reversal rate in Federal Circuit cases.2 In this essay, I suggest that the 
Supreme Court’s effect on patent law has actually been more limited, for two 
reasons in particular. First, the Supreme Court’s recent decisions, though 
substantial in number, have rarely involved the fundamental legal doctrines 
that directly ensure the inventiveness of patents and regulate their scope.3 
Second, the Supreme Court’s minimalist approach to opinion writing in 
patent cases frequently enables the Federal Circuit to ignore the Court’s 
changes to governing doctrine.  
I. THE SUPREME COURT’S INTEREST IN PATENT LAW 
Before fully explaining those arguments, it will help to summarize the 
ongoing debate about the Supreme Court’s proper role in the patent system 
and to consider why, exactly, the Supreme Court is so interested in patent 
law these days.  
On the Supreme Court’s role: One possible benefit of Supreme Court 
activity in patent law is that it can serve as the “percolating” force that patent 
law generally lacks because of the centralization of appeals in the Federal 
Circuit.4 Frequent Supreme Court review can create a dialogue between the 
Justices and the Federal Circuit about patent law and policy.5 Moreover, the 
possibility of Supreme Court review can incentivize Federal Circuit judges 
to be more vocal when they believe law reform is necessary by, for example, 
writing separate opinions and explicitly calling for en banc or Supreme Court 
review.6 
That said, many stakeholders perceive Supreme Court Justices as 
knowing little about patent law and the technology relevant to patent cases, 
at least as compared to the expert judges on the Federal Circuit.7 Critics have 
particularly assailed the Court’s decisions on patent-eligible subject matter, 
contending that the Court has adopted an amorphous test that is difficult for 
 
 
 2. Timothy B. Dyk, Thoughts on the Relationship Between the Supreme Court and the Federal 
Circuit, 16 CHI.-KENT J. INTELL. PROP. 67, 72 (2016). 
 3. Four recent decisions on patent-eligible subject matter are a conspicuous exception to this 
statement. I discuss those decisions in more detail below.  
 4. John M. Golden, The Supreme Court as “Prime Percolator”: A Prescription for Appellate 
Review of Questions in Patent Law, 56 UCLA L. REV. 657, 662-64 (2009). 
 5. Paul R. Gugliuzza, Saving the Federal Circuit, 13 CHI.-KENT J. INTELL. PROP. 350, 358-59 
(2014). 
 6. See id. at 356-57 (discussing the frequency of this behavior among Federal Circuit judges). 
 7. Greg Reilly, How Can the Supreme Court Not “Understand Patent Law”?, 16 CHI.-KENT J. 
INTELL. PROP. 292, 298 (2017). 
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lower courts and the PTO to apply and that has destroyed the predictability 
and certainty that is supposedly essential to innovation.8 
Many commentators have thoughtfully considered whether the 
Supreme Court should be deciding so many patent cases,9 reaching 
conclusions that range from optimism about the Court’s ability to improve 
the patent system10 to outright mockery of the Justices’ intellectual aptitude 
for patent law.11 But, for better or worse, the Supreme Court’s large docket 
of patent cases is unlikely to shrink soon. The Court has considered six patent 
cases in the 2016 Term, which is wrapping up as this essay goes to press. 
Those six cases build on three patent law decisions in the 2015 Term, three 
more in the 2014 Term, and six in the 2013 Term.12 Moreover, patent law is 
indisputably more visible to lawyers and to the general public today than it 
was a decade or two ago.13 Stories about patent law, patent litigation, and 
even the Federal Circuit itself are regular fixtures of leading newspapers,14 
including those likely to influence the decisionmaking of the Justices and 
their law clerks.15 In addition, patent reform is now a staple of Congress’s 
 
 
 8. See, e.g., Paul R. Michel, The Supreme Court Saps Patent Certainty, 82 GEO. WASH. L. REV. 
1751, 1761 (2014); David O. Taylor, Confusing Patent Eligibility, 83 TENN. L. REV. (forthcoming 2017) 
(manuscript at 3), http://ssrn.com/abstract=2754323. 
 9. As a small sample of the literature touching on this question, see Rochelle Cooper Dreyfuss, 
What the Federal Circuit Can Learn from the Supreme Court—and Vice Versa, 59 AM. U. L. REV. 787 
(2010); John F. Duffy, The Festo Decision and the Return of the Supreme Court to the Bar of Patents, 
2002 SUP. CT. REV. 273; Timothy B. Dyk, Does the Supreme Court Still Matter?, 57 AM. U. L. REV. 763 
(2008); Golden, supra note 4; Timothy R. Holbrook, Explaining the Supreme Court’s Interest in Patent 
Law, 3 IP THEORY 62 (2013); Peter Lee, The Supreme Assimilation of Patent Law, 114 MICH. L. REV. 
1413 (2016).  
 10. See, e.g., Dreyfuss, supra note 9, at 807; see also Duffy, supra note 9, at 342; Golden, supra 
note 4, at 720 (both perhaps best described as cautious optimism). 
 11. See Reilly, supra note 7, at 309. 
 12. For a comprehensive list of Supreme Court patent cases see Supreme Court Patent Cases, 
WRITTEN DESCRIPTION, http://writtendescription.blogspot.com/p/patents-scotus.html (last visited Apr. 
25, 2017). 
 13. Dyk, supra note 2, at 83. 
 14. See, e.g., Ashby Jones, Critics Fault Court’s Grip on Appeals for Patents, WALL ST. J. (July 6, 
2014), https://www.wsj.com/articles/critics-fault-courts-grip-on-appeals-for-patents-1404688219; Brent 
Kendall, Supreme Court to Hear Patent Case That Could Limit Venue Shopping, WALL ST. J. (Dec. 14, 
2016), https://www.wsj.com/articles/supreme-court-to-hear-patent-case-that-could-limit-venue-
shopping-1481749533; Steve Lohr, With Patent Litigation Surging, Creators Turn to Washington for 
Help, N.Y. TIMES (Apr. 29, 2015), https://www.nytimes.com/2015/04/30/technology/with-patent-
litigation-surging-creators-turn-to-washington-for-help.html. 
 15. Lawrence Baum & Neal Devins, Why the Supreme Court Cares About Elites, Not the American 
People, 98 GEO. L.J. 1515, 1542-44 (2010); see also Gregory N. Mandel, Institutional Fracture in 
Intellectual Property Law: The Supreme Court Versus Congress, 102 MINN. L. REV. (forthcoming 2017) 
(manuscript at 53-54, 58), https://ssrn.com/abstract=2926110 (suggesting that the Supreme Court’s recent 
decisions in intellectual property cases reflect an “elite popular opinion” that displays “a growing concern 
about the strength of intellectual property rights”). 
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agenda, and that legislative activity surely piques the Court’s interest.16 
Wide-ranging and high-profile policy debates about “patent trolls” likewise 
seem to have caught the Court’s attention.17 
Perhaps most importantly, members of the specialized Supreme Court 
bar—who have an enormous influence on the Court’s docket18—now 
frequently urge the Court to hear patent cases and argue those cases once 
certiorari is granted. For instance, Seth Waxman, the former Solicitor 
General, presented oral argument in four of the six patent cases argued in the 
2016 Term. His opponents included Carter Phillips, a former Assistant to the 
Solicitor General who has argued nearly a hundred Supreme Court cases; 
Kathleen Sullivan, the former Dean of Stanford Law School who has argued 
nearly a dozen Supreme Court cases; and Deanne Maynard, another former 
Assistant to the Solicitor General who has argued over a dozen Supreme 
Court cases. Supreme Court specialists such as Waxman, Phillips, Sullivan, 
Maynard, and others have also been arguing more frequently in the Federal 
Circuit in recent years.19 
In addition, the Justices’ law clerks frequently work for these Supreme 
Court specialists as summer associates or for brief stints before their time at 
the Court. The revolving door between the law firms pushing the Court to 
hear patent cases (at the behest of their clients, of course) and the Justices’ 
chambers, where law clerks have significant control over the petitions that 
emerge from the cert pool,20 likely cements the perception that patent cases 
are important and belong on the Court’s docket. In short, despite patent law’s 
reputation as a specialized area of practice, the field is plainly no longer, as 
 
 
 16. See J. Jonas Anderson, Patent Dialogue, 92 N.C. L. REV. 1049, 1069-70 (2014).  
 17. A few Supreme Court opinions have explicitly mentioned concerns about trolls. See, e.g., eBay 
Inc. v. MercExchange, L.L.C., 547 U.S. 388, 396 (2006) (Kennedy, J., concurring). For a synopsis of the 
controversies surrounding patent trolls, see generally Paul R. Gugliuzza, Patent Trolls and Patent 
Litigation Reform, in OXFORD HANDBOOKS ONLINE at 2-8 (2017), http://www.oxfordhandbooks.com. 
 18. Richard J. Lazarus, Advocacy Matters Before and Within the Supreme Court: Transforming the 
Court by Transforming the Bar, 96 GEO. L.J. 1487, 1490 (2008). 
 19. See, e.g., Acorda Therapeutics Inc. v. Mylan Pharms. Inc., 817 F.3d 755 (Fed. Cir. 2016) (Ted 
Olson and Paul Clement); TiVo Inc. v. EchoStar Corp., 646 F.3d 869 (Fed. Cir. 2011) (Waxman and Josh 
Rosenkranz); Kyocera Wireless Corp. v. Int’l Trade Comm’n, 545 F.3d 1340 (Fed. Cir. 2008) (Phillips 
and Ken Starr, among others); see also Unwired Planet, LLC v. Google Inc., No. 2015-1812, 2017 WL 
1229744 (Fed. Cir. Apr. 4, 2017) (denial of petition for rehearing en banc) (William Jay and Neal Katyal 
as principal counsel on the rehearing briefs). 
 20. David R. Stras, The Supreme Court’s Gatekeepers: The Role of Law Clerks in the Certiorari 
Process, 85 TEX. L. REV. 947, 996-97 (2007). 
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it was once derisively described, the domain of only “people wearing 
propeller hats.”21 
Framing the Supreme Court’s interest in patent law as enduring 
highlights important questions that scholars have not explored in much 
detail. As noted above, there is a rich literature debating whether the Court 
should be deciding patent cases, and much contemporary patent scholarship 
considers whether the Court has reached the correct results in those cases. 
Yet few scholars have considered whether the Court’s docket is filled with 
the right kind of patent cases,22 nor have many scholars considered how the 
manner in which the Court explains its rulings—separate and apart from the 
results reached—affects whether the Court’s rulings change the decisions of 
lower courts and the behavior of participants in the patent system.23 The 
remainder of this essay provides an initial exploration of those questions, 
suggesting that the Supreme Court may be too focused on areas of patent law 
with little potential to fix key problems in the patent system and that the 
Court often limits the impact of its decisions by inadequately explaining how 
lower courts and the PTO should implement them.  
II. THE SUPREME COURT’S PATENT DOCKET: TRANSSUBSTANTIVITY, 
HARMONIZATION, AND STATUTORY INTERPRETATION 
The first step in critiquing the Supreme Court’s selection of issues and 
judicial methodology is to understand precisely what the Court’s patent 
docket looks like. Most of that docket consists of cases with at least one of 
 
 
 21. Kimberly A. Moore, Are District Judges Equipped to Resolve Patent Cases?, 15 HARV. J. L. 
TECH. 1, 11 (2001) (quoting Judge Samuel Kent in O.I. Corp. v. Tekmar Co., No. 95-CV-113 (S.D. Tex. 
June 17, 1996)). 
 22. For consideration of a related question, specifically, in what circumstances should the Supreme 
Court decide to grant review, see Dreyfuss, supra note 9, at 799-800 (suggesting that the Court should 
intervene when “the Federal Circuit signal[s] the need for intervention” and that the “involvement of 
others (practitioners, the Solicitor General) . . . remain[s] important”); Golden, supra note 4, at 709-10 
(“There appear to be at least three traits that a good case for merits review should generally have: (1) the 
substantive question involved is not currently subject to meaningful debate in the courts below; (2) there 
is good reason to suspect that the Federal Circuit’s settled approach to that question is substantially 
inferior to a legally permissible alternative; and (3) the case at hand is a good vehicle for addressing the 
substantive question as part of determining the outcome of a dispute between the specific parties 
involved.”); see also Duffy, supra note 9, at 340-42 (praising the Supreme Court for relying on 
“specialized actors,” such as the Federal Circuit itself and the PTO, to identify the issues warranting the 
Court’s attention). 
 23. For one analysis of the Court’s judicial methodology in patent cases, see Peter Lee, Patent Law 
and the Two Cultures, 120 YALE L.J. 2, 71 (2010) (arguing that the Court, to facilitate adjudication of 
patent cases by district judges who are neither expert in patent law nor the relevant technology, should 
adopt “clearly defined” analytical frameworks coupled with “illustrative examples”). 
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the following characteristics: (1) the case involves what might be called a 
“transsubstantive” issue, that is, an issue that arises in all types of federal 
litigation, not just patent cases, such as issues of jurisdiction, procedure, and 
remedies;24 (2) the case presents the opportunity draw on or harmonize patent 
law with other areas of federal law; or (3) the case requires the Court to 
interpret a discrete provision of the patent statute.25  
Supreme Court patent cases involving transsubstantive issues abound. 
Notable examples include: eBay on the test for issuing an injunction upon a 
finding of infringement,26 MedImmune on declaratory judgment standing,27 
Medtronic on the burden of proof in declaratory judgment cases,28 Gunn v. 
Minton on subject matter jurisdiction,29 Teva on the standard of appellate 




 24. For an exploration of the meaning of the term “transsubstantive” and a critique of prevailing 
scholarship on the topic, see generally David Marcus, Trans-Substantivity and the Processes of American 
Law, 2013 BYU L. REV. 1191 (2013). 
 25. For an early effort at classifying patent cases in which the Supreme Court has granted review, 
see Rebecca S. Eisenberg, The Supreme Court and the Federal Circuit: Visitation and Custody of Patent 
Law, 106 MICH. L. REV. FIRST IMPRESSIONS 28, 29-30 (2007), which notes that the Court has tended to 
grant certiorari in cases in which some or all of the following factors existed: (1) “the Federal Circuit’s 
patent jurisprudence [was] at odds with the treatment of similar issues in other fields of law,” (2) “the 
Federal Circuit [had] departed from the Supreme Court’s own patent law decisions,” (3) internal divisions 
existed within the Federal Circuit, (4) the Solicitor General urged review, or (5) there was substantial 
amicus interest in the case. In more recent work, Peter Lee draws a distinction between “heartland” issues 
of substantive patent doctrine, such as validity and infringement, and “transcendent” issues that touch on 
both patent doctrine as well as other areas, such as standards of review, jurisdiction, and remedies. Lee, 
supra note 9, at 1450-51.  
 26. eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388, 390 (2006). 
 27. MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118, 145 (2007). 
 28. Medtronic, Inc. v. Mirowski Family Ventures, LLC, 134 S. Ct. 843, 852 (2013). 
 29. Gunn v. Minton, 133 S. Ct. 1059, 1064 (2013). 
 30. Teva Pharms. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 839 (2015). 
 31. In re TC Heartland LLC, 821 F.3d 1338 (Fed. Cir.), cert. granted sub nom., TC Heartland LLC 
v. Kraft Food Grp. Brands LLC, 137 S. Ct. 614 (2016). These transsubstantive cases, it should be noted, 
could be further divided into more granular categories or, perhaps more accurately, placed on a spectrum 
from, at one end, patent cases that are truly transsubstantive (in that the decisions also have clear 
consequences for non-patent cases), to, at the other end, patent cases that require the Court to simply 
apply (often well-settled) transsubstantive principles in the unique context of patent law. A quintessential 
example of the former is Carlsbad Technology, Inc. v. HIF Bio, Inc., in which the Supreme Court held, 
in a patent-related case on certiorari from the Federal Circuit, that the federal courts of appeals have 
jurisdiction to review district court orders declining to exercise supplemental jurisdiction under 28 U.S.C. 
§ 1367(c). 556 U.S. 635, 636 (2009). (Carlsbad is so transsubstantive that I am reluctant to even identify 
it in the text as a “patent case.”) Good examples of the latter include Teva, in which the Court simply 
applied the clear-error standard of Federal Rule of Civil Procedure 52(a)(6) in the context of patent law, 
and Medtronic, in which the Court held that in patent cases, just like in all other cases, the identity of the 
party bearing the burden of proof does not change simply because the suit is one for a declaratory 
judgment rather than for damages or an injunction.  
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These transsubstantive cases often provide the Court with opportunities 
to harmonize the law applicable to patent cases with more generally 
applicable principles of federal law. In Gunn, for instance, the Court 
synchronized the law under the patent-specific jurisdictional statute with 
case law on the general federal question statute.32 In Teva, the Court changed 
the standard of appellate review of patent claim construction to match the 
generally applicable clear-error standard in Federal Rule of Civil Procedure 
52(a)(6).33 And in eBay the Court demanded that courts apply a supposedly 
“traditional” four-element test for determining whether an injunction is 
warranted upon a finding of patent infringement.34 
The Supreme Court has also repeatedly harmonized (or considered 
harmonizing) patent law with other substantive areas of federal law, 
including other fields of intellectual property law. In Global Tech, for 
instance, the Court looked to criminal law’s doctrine of willful blindness to 
define the mental state required for induced patent infringement.35 And in 
Octane Fitness the Court discussed case law interpreting the Copyright Act’s 
fee shifting provision in articulating the standard for awarding attorneys’ 
fees under the Patent Act.36 In fact, in two patent cases in the current 2016 
Term, the Court has confronted questions identical to questions it recently 
resolved in the copyright context. In SCA Hygiene, the Court held that an 
infringer may not invoke the equitable doctrine of laches as a defense to a 
claim of patent infringement,37 just three years after holding that laches is 
not a defense to a claim for damages for copyright infringement.38 And in 
 
 
 32. Gunn, 133 S. Ct. at 1065-66 (citing, among other cases, Grable & Sons Metal Prods., Inc. v. 
Darue Eng’g & Mfg., 545 U.S. 308 (2005), and Merrell Dow Pharms. Inc. v. Thompson, 478 U.S. 804 
(1986)); see also 28 U.S.C. § 1331 (general federal question statute); id. § 1338(a) (conferring exclusive 
jurisdiction on the federal courts in cases “arising under” patent law). 
 33. Teva, 135 S. Ct. at 836. 
 34. eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388, 390 (2006); see also id. at 392 (asserting that 
application of the “traditional” test “is consistent with our treatment of injunctions under the Copyright 
Act”). For a scholarly analysis raising doubts about whether the test articulated in eBay is consistent with 
traditional equitable practice, see Mark P. Gergen, John M. Golden & Henry E. Smith, The Supreme 
Court’s Accidental Revolution? The Test for Permanent Injunctions, 112 COLUM. L. REV. 203, 207 
(2012). Also, there remains some dispute about whether the four points of analysis articulated in eBay 
are factors to be weighed or elements that must each be satisfied. I have called them elements in the text, 
in line with a recent Federal Circuit decision that appears to adopt that view. Nichia Corp. v. Everlight 
Ams., Inc., --- F.3d ---, 2017 WL 1521595, at *9 (Fed. Cir. Apr. 28, 2017) (noting that a party seeking a 
permanent injunction “must prove that it meets all four equitable factors”). 
 35. Global-Tech Appliances, Inc. v. SEB S.A., 563 U.S. 754, 766-71 (2011). 
 36. Octane Fitness, LLC v. ICON Health & Fitness, Inc., 134 S. Ct. 1749, 1756 (2014).  
 37. SCA Hygiene Prods. Aktiebolag v. First Quality Baby Prods., LLC, 137 S. Ct. 954, 959 (2017). 
 38. Petrella v. MGM, Inc., 134 S. Ct. 1962, 1977 (2014) (noting that in “extraordinary cases” laches 
could provide a defense from injunctive relief).  
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Impression Products v. Lexmark, which is under submission as this essay 
goes to press, the Court is considering whether a sale outside the United 
States exhausts U.S. patent rights,39 just four years after holding that a 
foreign sale exhausts a U.S. copyright.40 
Many of the Court’s recent patent cases have centered on the 
interpretation of discrete provisions of the Patent Act. Examples include Life 
Technologies on the meaning of “substantial” in § 271(f)(1),41 Samsung v. 
Apple on the meaning of “article of manufacture” in § 289,42 and a trio of 
cases on the meaning of inducement under § 271(b).43 Similarly, the pending 
Sandoz v. Amgen case44 raises difficult questions about how to interpret the 
Biologics Price Competition and Innovation Act, a statute designed to 
expedite FDA approval of generic biologic drugs. 
Interestingly, just as many of the Court’s transsubstantive patent cases 
present opportunities to harmonize the law applicable in patent cases with 
other areas of the law, many of these statutory interpretation cases involve 
issues that could be considered transsubstantive. The statutory interpretation 
issue in Samsung, for instance, was relevant to determining damages for 
design patent infringement.45 Also, the Octane Fitness case on the standard 
for awarding attorneys’ fees required the Court to interpret § 285 of the 
Patent Act, which permits the award of fees “in exceptional cases.”46 And 
Halo, on the issue of enhanced damages for patent infringement, required 
 
 
 39. Lexmark Int’l, Inc. v. Impression Prods., Inc., 816 F.3d 721 (Fed. Cir.), cert granted, 137 S. Ct. 
546 (2016).  
 40. Kirtsaeng v. John Wiley & Sons, Inc., 133 S. Ct. 1351, 1358 (2012). 
 41. Life Techs. Corp. v. Promega Corp., 137 S. Ct. 734, 743 (2017). Section 271(f)(1) imposes 
liability on anyone who supplies a “substantial portion of the components of a patented invention” and 
actively induces someone else to combine those components abroad in a manner that would infringe the 
patent if done in the United States. 35 U.S.C. § 271(f)(1).  
 42. Samsung Elecs. Co. v. Apple Inc., 137 S. Ct. 429, 434 (2016). Section 289 of the Patent Act 
permits the owner of an infringed design patent to recover the defendant’s “total profit” from its sales of 
the “article of manufacture” to which the patented design was applied. 35 U.S.C. § 289. In Samsung, the 
Court held that the “article of manufacture” is not necessarily the finished product sold to the public; it 
could be a component of that product. 137 S. Ct. at 436. 
 43. Commil USA, LLC v. Cisco Sys., Inc., 135 S. Ct. 1920, 1926 (2015); Limelight Networks, Inc. 
v. Akami Techs. Inc., 134 S. Ct. 2111, 2112 (2014); Global-Tech Appliances, Inc. v. SEB S.A., 563 U.S. 
754, 757 (2011). Section 271(b) of the Patent Act complements § 271(a)’s prohibition on direct 
infringement by providing that “[w]hoever actively induces infringement of a patent shall be liable as an 
infringer.” 35 U.S.C. § 271(b). 
 44. Amgen Inc. v. Sandoz Inc., 794 F.3d 1347 (Fed. Cir. 2015), cert. granted, 137 S. Ct. 808 (2017).  
 45. See Samsung, 137 S. Ct. 434-36.  
 46. Octane Fitness, LLC v. ICON Health & Fitness, Inc., 134 S. Ct. 1749, 1752 (2014). 
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the Court to interpret § 284, which provides that a court “may increase the 
damages” up to three times the amount awarded by the factfinder.47 
III. “FOUNDATIONAL” QUESTIONS OF PATENT LAW? 
In his article, Judge Dyk says that “most” of the Supreme Court’s recent 
patent cases “have involved important and foundational questions with 
enormous impacts on patent litigation.”48 But the brief review provided 
above suggests that the Court, with one notable exception I will discuss 
shortly, has actually issued few opinions involving the truly “foundational” 
provisions of the Patent Act—most notably, the requirements of 
patentability. Those provisions require patents to be, among other things, 
novel, nonobvious, and adequately disclosed.49 They directly serve patent 
law’s central policy of promoting innovation by ensuring the PTO awards 
patents only for inventions that are truly inventive, thoroughly described, and 
clearly claimed.  
Importantly, the lax application of those requirements has, by many 
accounts, caused significant problems in the modern patent system.50 But, 
unlike the issues on which the Supreme Court has fixated, the Patent Act’s 
provisions on patentability offer little statutory language on which to base a 
decision.51 And, by their very nature, they offer few opportunities to 
harmonize patent law with other areas of law. 
Though the Court has decided a remarkable thirty-three patent cases 
since 2006,52 it has decided precisely zero cases involving the novelty 
requirement of § 102. The Court has decided one case involving the 
disclosure requirements of § 112.53 But that case did not involve the 
 
 
 47. Halo Elecs., Inc. v. Pulse Elecs., Inc., 136 S. Ct. 1923, 1928 (2016). 
 48. Dyk, supra note 2, at 72. 
 49. 35 U.S.C. §§ 102, 103, 112. 
 50. See, e.g., JAMES BESSEN & MICHAEL J. MEURER, PATENT FAILURE: HOW JUDGES, 
BUREAUCRATS, AND LAWYERS PUT INNOVATORS AT RISK 10-11 (2008); Michael D. Frakes & Melissa 
F. Wasserman, Does the U.S. Patent and Trademark Office Grant Too Many Bad Patents? Evidence from 
A Quasi-Experiment, 67 STAN. L. REV. 613, 617 (2015). 
 51. Craig Allen Nard, Legal Forms and the Common Law of Patents, 90 B.U. L. REV. 51, 53 (2010). 
The barebones language of those provisions does not, however, stop the Court from trying to suggest that 
its decisions are dictated by statutory text. See, e.g., Bilski v. Kappos, 561 U.S. 593, 606-08 (2010) 
(rejecting a categorical bar on business method patents based on a textual analysis of the term “process” 
as used in § 101). 
 52. As of April 28, 2017, three additional patent cases remain pending on the Court’s merits docket. 
Supreme Court Patent Cases, supra note 12.  
 53. Nautilus, Inc. v. Biosig Instruments, Inc., 134 S. Ct. 2120 (2014). 
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fundamental prerequisites of enablement and written description,54 even 
though the very existence of the written description requirement has been 
vigorously debated among Federal Circuit judges in recent years.55 Rather, 
the Supreme Court’s sole case on § 112 involved the test for determining 
when a patent can be invalidated as indefinite—an issue that, though it arises 
in a large number of cases,56 is successful in a relatively narrow slice of 
them.57 And although the Court in Nautilus eased the legal requirements for 
invalidating a patent as indefinite,58 observers have questioned whether the 
decision has had much impact on the ground.59 
The Court has also decided only one case involving the nonobviousness 
requirement of § 103—“the sine qua non of patentability.”60 That case, to be 
sure, was a fairly high-profile decision. In KSR v. Teleflex, the Court 
deemphasized the “teaching, suggestion, or motivation” requirement 
imposed by the Federal Circuit, replacing it with a “flexible” analysis that 
permits a ruling of obviousness to be based on market demands, design 
incentives, or even common sense.61 KSR appears to have made it at least 
 
 
 54. The enablement requirement mandates that the invention be described in sufficient detail that a 
person of ordinary skill in the art could recreate the invention without undue experimentation. See Consol. 
Elec. Light v. McKeesport Light Co., 159 U.S. 465, 474 (1895). The written description requirement 
ensures that the inventor, at the time of filing the patent application, had actually invented what is claimed 
in the issued patent. See Gentry Gallery Inc. v. Berkline Corp., 134 F.3d 1473, 1479 (1998); see also 35 
U.S.C. § 112(a) (requiring the patent’s specification to “contain a written description of the invention, 
and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to 
enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to 
make and use the same”).  
 55. See Ariad Pharms., Inc. v. Eli Lilly & Co., 598 F.3d 1336 (Fed. Cir. 2010) (en banc). 
 56. John R. Allison, Mark A. Lemley & David L. Schwartz, Understanding the Realities of Modern 
Patent Litigation, 92 TEX. L. REV. 1769, 1782 (2014). 
 57. John R. Allison, Mark A. Lemley & David L. Schwartz, Our Divided Patent System, 82 U. CHI. 
L. REV. 1073, 1105 (2015) (reporting that indefiniteness challenges succeed mainly in cases involving 
software and computer-related inventions). 
 58. Under the Federal Circuit’s prior case law, a patent claim was invalid as indefinite only if it was 
“insolubly ambiguous.” Nautilus, 134 S. Ct. at 2122. The Supreme Court, by contrast, held that “a patent 
is invalid for indefiniteness if its claims, read in light of the specification . . . and the prosecution history, 
fail to inform, with reasonable certainty, those skilled in the art about the scope of the invention.” Id. at 
2123. 
 59. Compare Jason Rantanen, Teva, Nautilus, and Change Without Change, 18 STAN. TECH. L. 
REV. 430, 432 (2015) (arguing that, after Nautilus, “[i]t seems to be business as usual at the Federal 
Circuit”), with Lisa Ouellette, Dow v. NOVA: Maybe Nautilus Does Matter, WRITTEN DESCRIPTION 
(Aug. 28, 2015), http://writtendescription.blogspot.com/2015/08/dow-v-nova-maybe-nautilus-does-
matter.html (discussing the Federal Circuit’s decision in Dow Chemical Co. v. NOVA Chemicals Corp., 
803 F.3d 620, 630 (Fed. Cir. 2015), which invalidated several patent claims and noted that “there can be 
no serious question that Nautilus changed the law of indefiniteness”). 
 60. Roanwell Corp. v. Plantronics Inc., 429 U.S. 1004, 1005 (1976) (White, J., dissenting from the 
denial of certiorari). 
 61. KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398, 417-22 (2007). 
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somewhat easier to demonstrate that a claimed invention is impermissibly 
obvious,62 though, as discussed below, the Federal Circuit has sometimes 
resisted the more flexible framework articulated by the Supreme Court.63 
The most notable exception to the Supreme Court’s reluctance to 
consider the requirements of patentability is in the area of patent-eligible 
subject matter. In four decisions in the past seven years, the Court has 
invigorated that requirement, prohibiting patents directed to laws of nature, 
natural phenomena, or abstract ideas unless they also contain an “inventive 
concept.”64 Eligibility doctrine polices both patent breadth (by ensuring 
patents do not claim the building blocks of future innovation) and originality 
(by ensuring inventiveness)—something both the Federal Circuit and the 
PTO had trouble doing in the 1990s and early 2000s. 
But many observers have complained about the Supreme Court’s 
emergent case law in this area. These critics contend that the test for patent 
eligibility adopted by the Supreme Court is too amorphous for the courts and 
the PTO to apply predictably65 and that some of the Court’s opinions are 
internally inconsistent.66 They also argue that the eligibility requirement 
serves no meaningful policy objective not already served by the 
requirements of novelty, nonobviousness, and adequate disclosure.67 In 
addition, the invigorated eligibility requirement may lead courts to 
sometimes invalidate patents on meritorious inventions. The quintessential 
example according to many commentators68 is Ariosa v. Sequenom, in which 
the Federal Circuit invalidated a patent on a non-invasive prenatal genetic 
 
 
 62. See, e.g., Glynn S. Lunney, Jr. & Christian T. Johnson, Not So Obvious After All: Patent Law’s 
Nonobviousness Requirement, KSR, and the Fear of Hindsight Bias, 47 GA. L. REV. 41, 44 (2012); Jason 
Rantanen, The Federal Circuit’s New Obviousness Jurisprudence: An Empirical Study, 16 STAN. TECH. 
L. REV. 709, 713 (2013). 
 63. See infra notes 104-105 and accompanying text. 
 64. E.g., Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566 U.S. 66, 72-73 (2012). 
 65. See, e.g., David O. Taylor, Amending Patent Eligibility, 50 U.C. DAVIS L. REV. (forthcoming 
2017) (manuscript at 3), https://ssrn.com/abstract=2853700. 
 66. See Peter Lee, The Supreme Court’s Myriad Effects on Scientific Research: Definitional Fluidity 
and the Legal Construction of Nature, 5 U.C. IRVINE L. REV. 1077, 1106 n.223 (2015) (collecting 
criticism of the Supreme Court’s decision in Ass’n for Molecular Pathology v. Myriad Genetics, Inc., 133 
S. Ct. 2107 (2013)). 
 67. See, e.g., J. Jonas Anderson, Applying Patent-Eligible Subject Matter Restrictions, 17 VAND. J. 
ENT. & TECH. L. 267, 280 (2015) (collecting criticism); see also John M. Golden, Redundancy: When 
Law Repeats Itself, 94 TEX. L. REV. 629, 699-710 (2016) (analyzing the costs and benefits of eligibility’s 
overlap with other validity doctrines). 
 68. See, e.g., Dmitry Karshtedt, Photocopies, Patents, and Knowledge Transfer: “The Uneasy 
Case” of Justice Breyer’s Patentable Subject Matter Jurisprudence, 69 VAND. L. REV. 1739, 1770-71 
(2016). 
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test that was widely viewed as a scientific and medical breakthrough69 
because the test involved a “natural law”—the presence of fetal DNA in the 
mother’s bloodstream.70 The judges of the Federal Circuit, in numerous 
separate opinions, strongly urged the Supreme Court to grant review.71 But, 
to the surprise of many, the Court denied certiorari.72 
Ariosa aside, what explains the Supreme Court’s fixation on patent 
eligibility to the exclusion of other requirements of patentability? The 
Court’s resurgent interest in eligibility doctrine can be traced to Justice 
Breyer’s 2006 dissent from the dismissal of certiorari in Lab Corp. v. 
Metabolite, in which he, joined by Justices Stevens and Souter, emphasized 
a view that eligibility has a quasi-constitutional dimension, writing that “the 
reason for the exclusion [of laws of nature from patent eligibility] is that 
sometimes too much patent protection can impede rather than ‘promote the 
Progress of Science and useful Arts,’ the constitutional objective of patent 
and copyright protection.”73 Eligibility’s lofty status might help explain the 
Supreme Court’s gravitation toward that issue and away from other 
patentability requirements, such as novelty, adequate disclosure, and even 
nonobviousness, which seem technical and mundane in comparison. In a 
similar vein, the fuzzy nature of the eligibility test and its search for an 
“inventive concept” allows the Court to consider and write about the 
 
 
 69. Rachel Rebouché, Testing Sex, 49 U. RICH. L. REV. 519, 527 (2015). 
 70. Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371, 1378 (Fed. Cir. 2015). 
 71. Id. at 1381 (Linn, J., concurring) (“The new use of the previously discarded maternal plasma to 
achieve such an advantageous result is deserving of patent protection. . . . But for the sweeping language 
in the Supreme Court’s Mayo opinion, I see no reason, in policy or statute, why this breakthrough 
invention should be deemed patent ineligible.”); Ariosa Diagnostics, Inc., v. Sequenom, Inc., 809 F.3d 
1282, 1287 (Fed. Cir. 2015) (Lourie, J., concurring in the denial of rehearing en banc) (“[I]t is unsound 
to have a rule that takes inventions of this nature out of the realm of patent-eligibility on grounds that 
they only claim a natural phenomenon plus conventional steps, or that they claim abstract concepts.”); id. 
(Dyk, J., concurring in the denial of rehearing en banc) (“I share the concerns of some of my colleagues 
that a too restrictive test for patent eligibility under 35 U.S.C. § 101 with respect to laws of nature 
(reflected in some of the language in Mayo) may discourage development and disclosure of new 
diagnostic and therapeutic methods in the life sciences . . . . This leads me to think that some further 
illumination as to the scope of Mayo would be beneficial in one limited aspect.”). 
 72. Sequenom, Inc. v. Ariosa Diagnostics, Inc., 136 S. Ct. 2511 (2016). 
 73. Lab. Corp. of Am. Holdings v. Metabolite Labs., Inc., 548 U.S. 124, 126-27 (2006) (Breyer, J., 
dissenting from the dismissal of the writ of certiorari) (quoting U.S. CONST. art. I, § 8, cl. 8). For an 
analysis vehemently challenging the notion that the eligibility requirement stems from the Constitution, 
see Taylor, supra note 65, at 15-22. 
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patentability of inventions in general terms without digging into more 
specialized legal doctrines74 or the details of the relevant technology.75  
Whatever spurred the Court’s initial interest in eligibility doctrine, the 
denial of certiorari in Ariosa suggests that the Court’s enthusiasm for the 
issue may be waning. It is of course precarious to read anything into a denial 
of certiorari. But the Court’s refusal to hear such a high-profile and 
controversial case—in an area of patent law in which the Court has been 
extraordinarily active—might demonstrate that the criticism of the Court’s 
eligibility jurisprudence has dissuaded the Court from tinkering with the 
doctrine any further. 
Yet further disruption of patent law’s validity doctrines could be 
beneficial. Despite the patent system’s purpose to incentivize innovation,76 
in some technological fields, the patent system today may be thwarting 
innovation because many patents represent minimal advances in the state of 
the art and provide poor notice of their boundaries.77 Those poor quality 
patents facilitate litigation, heavily concentrated in the U.S. District Court 
for the Eastern District of Texas, in which patentees file suit with no intention 
of actually litigating; they are instead leveraging litigation costs to extract a 
quick settlement.78 Though the judges of the Eastern District are partly to 
blame for adopting rules and practices that encourage nuisance suits,79 the 
root cause of these dynamics is the existence of many patents that are not 
inventive and that are too broad. The Supreme Court could play an important 
role in improving the patent system by looking beyond the generalities of 
patent eligibility and seriously engaging the requirements of the Patent Act 
that are explicitly designed to ensure that patents are inventive, adequately 
disclosed, and clearly claimed. 
 
 
 74. Cf. Karshtedt, supra note 68, at 1777-81 (describing how the Court could have reached the same 
results in recent eligibility cases through doctrines developed under the Patent Act’s novelty provision). 
 75. More on the Court’s possible aversion to technology—and ways in which it might be 
overcome—below. See infra note 98 and accompanying text.  
 76. See generally Robert P. Merges, Philosophical Foundations of IP Law: The Law and Economics 
Paradigm, in 1 RESEARCH HANDBOOK ON THE ECONOMICS OF IP LAW (Peter S. Menell, Ben Depoorter 
& David Schwartz, eds., forthcoming), https://ssrn.com/abstract=2920713. 
 77. See generally DAN L. BURK & MARK A. LEMLEY, THE PATENT CRISIS AND HOW THE COURTS 
CAN SOLVE IT 30-31 (2009). 
 78. Mark A. Lemley & A. Douglas Melamed, Missing the Forest for the Trolls, 113 COLUM. L. 
REV. 2117, 2126 (2013). 
 79. J. Jonas Anderson, Court Competition for Patent Cases, 163 U. PA. L. REV. 631, 651-54 (2015); 
Daniel Klerman & Greg Reilly, Forum Selling, 89 S. CAL. L. REV. 241, 243 (2016); Brian J. Love & 
James Yoon, Predictably Expensive: A Critical Look at Patent Litigation in the Eastern District of Texas, 
20 STAN. TECH. L. REV. 1, 21 (2017). 
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IV. MAKING REAL CHANGES 
So, how, exactly, could the Supreme Court make meaningful changes 
to the substance of patent law? Some hints can be found in areas of patent 
law in which the Court’s recent decisions have clearly impacted litigants’ 
behavior and lower courts’ decisionmaking. Take patent eligibility, for 
example. The doctrine, to be sure, is not perfectly consistent (though new, 
common law-like doctrines often take time to evolve from unpredictable 
standards to more certain rules).80 Yet, as I suggest in a forthcoming article, 
the eligibility requirement fills an important procedural gap in patent law.81 
Because courts treat eligibility, unlike other prerequisites of patentability, as 
a pure question of law, it provides a mechanism to invalidate plainly invalid 
patents at the pleadings stage—something that patent law has never 
previously had and that can be an important tool to eliminate nuisance suits.82 
Indeed, the number of invalidity decisions rendered before discovery 
begins—and litigation costs begin to escalate quickly—has increased 
dramatically since the Supreme Court strengthened the eligibility 
requirement.83 
As this procedural justification for eligibility doctrine suggests, it is not 
only the substantive rules adopted by the Court that matter in effecting 
meaningful change on the ground. The manner in which the Court changes 
substantive law can be important, too. KSR illustrates. In that case, the Court 
granted review to reconsider a Federal Circuit doctrine that had been settled 
law for two decades. Not only did the Court reject the “rigid rule” embraced 
by the Federal Circuit, it applied the new test to the facts of the case, 
demonstrating the “expansive and flexible” mode of analyzing obviousness 
that the opinion endorsed. The Court provided a similar demonstration in 
eligibility cases such as Mayo, where the Court articulated the legal 
 
 
 80. See Keith N. Hylton, Patent Uncertainty: Toward A Framework with Applications, 96 B.U. L. 
REV. 1117, 1148 (2016). For an argument that the Supreme Court has erred by insisting on standard-like 
tests for eligibility when clear rules might be more appropriate, see David O. Taylor, Formalism and 
Antiformalism in Patent Law Adjudication: Rules and Standards, 46 CONN. L. REV. 415, 494 (2013). 
 81. Paul R. Gugliuzza, Quick Decisions in Patent Cases, 106 GEO. L.J. (forthcoming 2017-18) (on 
file with author). 
 82. Id. at 30; see also U.S. FED. TRADE COMM’N, PATENT ASSERTION ENTITY ACTIVITY 4 (2016), 
https://www.ftc.gov/system/files/documents/reports/patent-assertion-entity-activity-ftc-
study/p131203_patent_assertion_entity_activity_an_ftc_study_0.pdf (describing the behavior of 
numerous patent assertion entities (PAEs) as “consistent with nuisance litigation”). 
 83. See Gugliuzza, supra note 81, at 35 (reporting that the number of pleading-stage eligibility 
dismissals has increased from one in 2010, the year of the Supreme Court’s first recent eligibility decision, 
Bilski v. Kappos, 561 U.S. 593 (2010), to seventy-five in 2016). 
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framework—first, identify the abstract ideas or natural laws, then disregard 
them and analyze what remains for an “inventive concept”—and applied that 
framework to invalidate several of the patents involved. 
By, essentially, “showing its work,” as it did in KSR and the eligibility 
cases, the Court constrained the ability of the Federal Circuit and the PTO to 
disregard the Court’s doctrinal changes.84 As noted, some evidence suggests 
that invalidity decisions on the ground of obviousness have increased after 
KSR.85 And the guidance the PTO provides to its examiners on the question 
of eligibility hews very closely to the factual analyses provided by both the 
Supreme Court in decisions such as Mayo and the Federal Circuit in 
decisions following in its wake.86 
Unfortunately, engagement with core patent law—much less applying 
the law to the underlying facts of the case—is not a consistent mark of 
Supreme Court patent jurisprudence. The typical setup of a Supreme Court 
patent case is that the Court overturns a rigid Federal Circuit rule that appears 
inconsistent with doctrine in another area of the law or with clear statutory 
language. The Court then replaces that rule with a more context-sensitive 
standard.87 But, not infrequently, the Court refuses to elaborate on what the 
new standard means, declines to apply the new standard to the facts of the 
case, or both. 
Though some might celebrate Supreme Court opinions that are limited 
in scope for reflecting judicial humility,88 this humility gives the Federal 
Circuit wide berth to continue business as usual. For instance, in Nautilus, 
the Supreme Court ruled that a patent could be invalidated as indefinite if it 
failed to inform, with “reasonable certainty,” a person of ordinary skill in the 
art about the scope of the invention.89 But the Court refused to apply this new 
standard90 even though indefiniteness is a matter of claim construction, 
which is a question of law to be resolved by the judge.91 Not surprisingly, 
the Federal Circuit on remand reached the same result it had reached in the 
 
 
 84. For a parallel argument that the Supreme Court should “enable” its rulings by providing concrete 
examples of its holdings in action, see Lee, supra note 23, at 64-65.  
 85. See Lunney & Johnson, supra note 62. 
 86. See U.S. PAT. & TRADEMARK OFF., INTERIM GUIDANCE ON PATENT SUBJECT MATTER 
ELIGIBILITY, 79 Fed. Reg. 74,618 (2014). 
 87. Kelly Casey Mullally, Legal (Un)certainty, Legal Process, and Patent Law, 43 LOY. L.A. L. 
REV. 1109, 1130 (2010). 
 88. See, e.g., Duffy, supra note 9, at 341. 
 89. Nautilus, Inc. v. Biosig Instruments, Inc., 134 S. Ct. 2120, 2124 (2014). 
 90. Id. at 2131. 
 91. Teva Pharms. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 837 (2015). 
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opinion reviewed by the Supreme Court, taking a seemingly sarcastic jab at 
the Court’s new indefiniteness standard along the way.92 
The Court’s minimalist approach to writing patent opinions also 
perpetuates uncertainty about what, exactly, the law is. In Samsung v. Apple, 
for instance, the Court held that the “article of manufacture” for which the 
infringer’s total profits could be awarded under § 289 could be something 
less than the finished product sold to consumers.93 But the Court did not 
determine whether Samsung’s infringing smartphones or merely some 
component of them were the relevant “article of manufacture” in the case at 
hand.94 Though perhaps the Court could be excused for not resolving that 
factual issue on the record presented, the Court refused even to offer any 
legal guidance to the lower courts about how to determine what, precisely, 
is the relevant article. It instead remanded both issues to the Federal Circuit,95 
which, in turn, remanded both issues to the district court.96 Other examples 
of the Supreme Court’s reluctance to elaborate on the law or to engage the 
facts of the case are easy to find.97 
If the Supreme Court is interested in making legal reforms that actually 
change the patent system, the Court may need to issue decisions, like KSR 
and some of its eligibility decisions, that are more substantial in content and 
that are more explicit about how changes in the law alter the outcomes of 
particular cases. The Court might also need to overcome its seeming 
hesitance to engage the underlying technology, which is evident in decisions 
like Nautilus, where the Court did not apply its new indefiniteness standard 
 
 
 92. Biosig Instruments, Inc. v. Nautilus, Inc., 783 F.3d 1374, 1379 (Fed. Cir. 2015) (“The Court 
has . . . modified the standard by which lower courts examine allegedly ambiguous claims; we may now 
steer by the bright star of ‘reasonable certainty,’ rather than the unreliable compass of ‘insoluble 
ambiguity.’”). 
 93. Samsung Elecs. Co. v. Apple Inc., 137 S. Ct. 429, 435 (2016). 
 94. Id. at 436. 
 95. Id. 
 96. Apple Inc. v. Samsung Elecs. Co., No. 2014-1335, 2017 WL 490419 (Fed. Cir. Feb. 7, 2017). 
 97. See, e.g., Life Techs. Corp. v. Promega Corp., 137 S. Ct. 734, 743 (2017) (holding that a single 
component cannot constitute a “substantial” portion of an invention’s components for the purpose of 
infringement under § 271(f)(1), see supra note 41, but refusing to offer guidance about how many 
components would be sufficient to establish infringement); eBay Inc. v. MercExchange, L.L.C., 547 U.S. 
388, 394 (2006) (“[W]e take no position on whether permanent injunctive relief should or should not 
issue in this particular case . . . .”). It should be noted that, although the Court in eBay did not apply the 
test it articulated to the facts of the case, Justice Kennedy’s concurrence, which made the very specific 
point that non-practicing entities should rarely receive injunctions, has effectively dictated lower courts’ 
decisionmaking. eBay, 547 U.S. at 396-97 (Kennedy, J., concurring); Ryan T. Holte, The 
Misinterpretation of eBay v. MercExchange and Why: An Analysis of the Case History, Precedent, and 
Parties, 18 CHAPMAN L. REV. 677, 682 (2015).  
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to the case at hand even though it was well-situated to do so.98 Though one 
might suggest that lay judges (including Supreme Court Justices) are 
incapable of developing the technological proficiency needed to understand 
patent disputes,99 the certiorari process gives the Supreme Court the ability 
to set its own agenda and develop the law through cases that involve 
technology that is relatively straightforward, such as the automotive gas 
pedals at issue in KSR, or that has been clearly explained by the parties—a 
criterion that should not be hard to satisfy given the increasing presence of 
the elite Supreme Court bar in patent cases. To be sure, simple facts could 
limit how instructive the Court’s decision is to lower courts that must grapple 
with more complex technology. But the Court could at least partially cope 
with any concerns about technological complexity through wise screening at 
the certiorari stage. 
To effect real change in the patent system, the Supreme Court might 
also need to decide multiple cases on a given issue to reinforce its decisions 
against resistance from the Federal Circuit and the PTO. One reason the 
Court kept returning to eligibility may have been the skepticism about 
eligibility doctrine that prevailed among some judges of the Federal 
Circuit.100 The Court’s repeated engagement with one issue of patent law was 
not unprecedented. For example, beginning with Graham v. John Deere 
Co.,101 the Court in the 1960s and 1970s decided a half dozen cases on the 
issue of obviousness.102 In KSR, the Court discussed several of those cases 
as illustrating proper application of the obviousness doctrine.103 A similar, 
 
 
 98. Another oft-cited example of the Court’s hesitance to engage with technology is Justice Scalia’s 
concurrence in Myriad, in which he agreed with the ruling that isolated DNA is not patent eligible but 
refused to join the “portions of the . . . opinion going into fine details of molecular biology” because he 
was “unable to affirm those details on [his] own knowledge or even [his] own belief.” Ass’n for Molecular 
Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107, 2120 (2013) (Scalia, J., concurring in part and 
concurring in the judgment). Interestingly, although Justice Scalia’s choice of wording could easily be 
caricatured as reflecting a disbelief in basic biology, his concern about the accuracy of the science 
described in the majority opinion seems to have been justified. See Ian Samuel, Did Justice Scalia Believe 
in Dinosaurs? An Investigation, MEDIUM (Dec. 24, 2016), https://medium.com/@isamuel/did-justice-
scalia-believe-in-dinosaurs-an-investigation-79cd99e3559.  
 99. See Michael Goodman, What’s So Special About Patent Law?, 26 FORDHAM INTELL. PROP., 
MEDIA & ENT. L.J. 797, 839 (2016). Also see the discussion of Myriad in the previous footnote.  
 100. See, e.g., CLS Bank Int’l v. Alice Corp., 717 F.3d 1269 (Fed. Cir. 2013) (en banc), aff’d, 134 S. 
Ct. 2347 (2014) (deeply divided en banc decision on the eligibility of a patent on computer software). 
 101. 383 U.S. 1 (1966). 
 102. See Graham, 383 U.S. 1; United States v. Adams, 383 U.S. 39 (1966); Anderson’s-Black Rock, 
Inc. v. Pavement Salvage Co., 396 U.S. 57 (1969); Dann v. Johnston, 425 U.S. 219 (1976); Sakraida v. 
Ag Pro, Inc., 425 U.S. 273 (1976); see also Graham, 383 U.S. at 26-37 (discussing the consolidated cases 
of Calmar, Inc. v. Cook Chemical Co. and Colgate-Palmolive Co. v. Cook Chemical Co.). 
 103. KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398, 415-17 (2007). 
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recurrent engagement with obviousness might be particularly warranted 
today in light of recent Federal Circuit decisions in tension with the flexible 
analysis embraced in KSR. Particularly questionable decisions limit the use 
of common sense104 and insist that a patent challenger “must” prove a 
motivation to combine the teachings of prior art references.105 
To summarize the argument thus far: the sheer quantity of patent cases 
decided by the Supreme Court in recent years might make it seem as if the 
Court is serving as a percolating force in patent law by disrupting ossified 
doctrine and engaging in independent analyses of what the law should be.106 
But, with the exception of eligibility doctrine, the Court has hardly brought 
patent law to a boil. Decisions on remedial issues, such as eBay, which made 
it more difficult for non-practicing entities to obtain injunctive relief,107 and 
Octane Fitness, which made it easier to obtain attorneys’ fees,108 have 
changed outcomes somewhat. But the key doctrines governing novelty, 
nonobviousness, and disclosure have remained relatively static. Perhaps we 
should not be surprised to see evidence that, despite seemingly significant 
changes in the law in the past decade, the primary behavior of participants in 
the patent system has not changed much.109 
V. CAVEATS AND CLARIFICATIONS 
Before considering how litigants and advocates might persuade the 
Supreme Court to engage patent law’s foundational issues in ways that affect 
 
 
 104. See, e.g., Arendi S.A.R.L. v. Apple Inc., 832 F.3d 1355, 1361 (Fed. Cir. 2016) (holding that 
common sense typically cannot be invoked to supply a claim limitation not found in the prior art), cert. 
denied sub nom., Google Inc. v. Arendi S.A.R.I., No. 16-626, 2017 WL 1040877 (U.S. Mar. 20, 2017); 
In re Van Os, 844 F.3d 1359, 1361 (Fed. Cir. 2017) (demanding that “obviousness findings grounded in 
common sense . . . contain explicit and clear reasoning providing some rational underpinning why 
common sense compels a finding of obviousness”) (internal quotation marks omitted).  
 105. Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., 845 F.3d 1357, 1372 (Fed. Cir. 2017). For 
another critique of the rigidity of post-KSR Federal Circuit case law, see Douglas L. Rogers, Federal 
Circuit’s Obviousness Test for New Pharmaceutical Compounds: Gobbledygook?, 14 CHI.-KENT J. 
INTELL. PROP. 49, 105 (2014) (criticizing the “lead compound” doctrine used by the Federal Circuit for 
determining the patentability of pharmaceutical inventions). 
 106. On the benefits of percolation in the more traditional context, that is, among the regional federal 
courts of appeals, see generally Samuel Estreicher & John E. Sexton, A Managerial Theory of the 
Supreme Court’s Responsibilities: An Empirical Study, 59 N.Y.U. L. REV. 681, 699 n.68 (1984). 
 107. Christopher B. Seaman, Permanent Injunctions in Patent Litigation After eBay: An Empirical 
Study, 101 IOWA L. REV. 1949, 1987-90 (2016).  
 108. Hannah Jiam, Fee-Shifting and Octane Fitness: An Empirical Approach Toward Understanding 
“Exceptional,” 30 BERKELEY TECH. L.J. 611, 623 (2015). 
 109. Mark A. Lemley, The Surprising Resilience of the Patent System, 95 TEX. L. REV. 1, 2 (2016) 
(arguing, based on metrics such as the quantity of patent applications filed, the number of patents issued, 
and the frequency of patent litigation, that changes in patent law have not significantly changed behavior). 
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meaningful change, let me offer a few caveats and clarifications to the 
analysis provided so far. 
To start, one might reasonably note that the validity issues on which I 
have mainly focused are not the only “foundational” issues in patent law; 
doctrines on infringement could be considered foundational, too.110 
Similarly, one might defend the Court’s relative inattention to validity on a 
“rational ignorance” theory—the idea that because so many issued patents 
are never asserted, the Court’s energy is best directed to issues relevant only 
to patent litigation, such as infringement and remedies.111  
Yet the Supreme Court in recent years has shied away from core issues 
of infringement, just as it has done with validity. For example, the Court has 
decided a case on infringement under the relatively obscure provision of 
§ 271(f),112 but it has not decided a case involving the far more frequently 
litigated direct infringement provision of § 271(a). Similarly, the Court has 
not decided any case involving the substantive law of claim construction, 
only procedural cases such as Markman and Teva,113 as well as Cuozzo, in 
which the Court simply applied the deferential Chevron framework to hold 
that the standard of claim construction applied by the PTO in certain post-
issuance proceedings was a reasonable exercise of statutory authority.114 As 
for remedies, the Court has not addressed the core damages issues of lost 
profits and reasonable royalties, which patentees seek in practically every 
case, but it has decided more fringe remedial issues related to attorneys’ fees 
in Octane Fitness,115 willful infringement in Halo,116 and the laches defense 
in SCA Hygiene.117  
That said, eBay was plainly a consequential decision on the remedies 
for patent infringement.118 The Court has also decided cases on infringement 
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under the doctrine of equivalents (though none since 2002),119 as well as 
several cases on indirect infringement under § 271(b).120 The bottom line for 
this short essay, however, is that the Supreme Court’s recent patent 
decisions—though substantial in number—have often been trivial in content, 
even if there are a few exceptions. By and large, that claim holds true on 
issues of infringement and remedies as well as validity. 
One might also object to the characterization of the Court’s recent 
validity decisions as trivial. Specifically, what about the four eligibility 
decisions, which have changed the substance of patent law and the process 
of patent litigation in significant ways? Eligibility doctrine was mostly a 
dead letter until the Supreme Court got involved in 2010,121 but the issue is 
now litigated in many cases. Congress even created a new PTO proceeding, 
covered business method review, to scrutinize patents that are particularly 
susceptible to eligibility challenges.122  
Yet Supreme Court decisions on novelty, nonobviousness, and the 
disclosure doctrines would still be useful for at least two reasons. First, as 
explained above, eligibility is well-designed for quickly invalidating plainly 
invalid patents. However, as the years go by and the PTO and litigants adjust 
to the new legal regime, it seems likely that fewer and fewer plainly invalid 
patents will be asserted. Possible evidence of this trend can already be seen 
in the falling rates at which courts are granting motions to dismiss on 
eligibility grounds.123 Second, although eligibility is a useful tool for courts 
to quickly invalidate patents, it is not an ideal tool for examiners because the 
eligibility analysis is driven by broad policy concerns about limiting 
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monopolization of basic research tools and by common law-like analyses of 
case law.124 Although the PTO has tried to distill the courts’ eligibility case 
law into examples that examiners can reliably apply en masse, examiners are 
probably better suited to deploy more fact- and technology-intensive validity 
doctrines such as novelty, nonobviousness, enablement, and written 
description.  
VI. SHAPING THE SUPREME COURT’S AGENDA 
Litigants and advocates could take several steps to persuade the 
Supreme Court to become more active in core areas of patent law. In terms 
of private actors, patent disputes often involve repeat players who are well-
suited to seek systemic reform in the courts. For instance, in the TC 
Heartland case currently pending before the Supreme Court,125 a private 
litigant engaged in a concerted effort from the earliest stages of the case to 
challenge the Federal Circuit venue doctrine that permits patent litigation to 
cluster in places like East Texas,126 even though that doctrine has been settled 
law for nearly thirty years. Indeed, the TC Heartland case is a surprising 
vehicle for considering the venue issue because the case was actually filed 
in Delaware, not Texas.127 
The public sector also contains actors who could inspire the Court to 
engage core questions of patentability more frequently and in more factual 
detail. As noted above, Federal Circuit judges can play a critical signaling 
role through the separate opinions they write at both the panel and en banc 
stages. The Supreme Court frequently grants review when the Federal 
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Circuit is deeply fractured, as was the case in recent decisions on patent 
eligibility,128 claim construction,129 and other issues.130  
Sometimes, however, the doctrine in need of reform is relatively 
ossified at the Federal Circuit, as was the case with obviousness before KSR. 
In that circumstance, it is worth noting that Solicitor General has significant 
sway over the Supreme Court, particularly on patent matters.131 That office 
is staffed with appellate generalists, which is probably another reason the 
Court gravitates toward patent cases that provide opportunities to harmonize 
patent law with other fields or to interpret statutory language, rather than 
fact- or technology-intensive validity disputes. But, as a body within the 
executive branch, the Solicitor General’s office is well-positioned to 
coordinate a dialogue among numerous actors who are sensitive to 
innovation law and policy, including the PTO (and especially its Solicitor’s 
office, which handles Federal Circuit appeals and sometimes challenges the 
Federal Circuit’s case law132), the Department of Justice, the Federal Trade 
Commission, the National Institutes of Health, and more.133 All of those 
actors are well-positioned to identify areas of patent law in need of reform, 
including areas where the doctrine appears to be well-settled, and to urge the 
Solicitor General to support private parties who seek Supreme Court 
review.134 They can also leverage their expertise to elaborate on specific 
outcomes or, at minimum, to reinforce the importance of giving clear 
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guidance to lower courts and the PTO about how to apply the law announced 
in a particular decision, day in and day out. 
CONCLUSION 
With the exception of its eligibility decisions, the Supreme Court, for 
now, seems content to nibble around the edges of patent law. Though the 
Supreme Court might seem like the Supreme Court of patents, most of its 
recent patent rulings involve transsubstantive issues or matters of statutory 
interpretation that have marginal significance in most cases and a tenuous 
relationship to innovation incentives. Unless the Court becomes willing to 
engage core questions of patent law and to write its opinions in a less 
minimalist fashion, it seems unlikely the Court will effect revolutionary 
changes in the patent system. 
